Connect Sign InAACC 2017 Booth Presentation: Advances in Viral Hepatitis Testing
The landscape of laboratory testing for viral hepatitis is rapidly evolving. The introduction of direct-acting antiviral agents has revolutionized management of hepatitis C virus (HCV) infections; but significant challenges remain in identifying, diagnosing, and managing therapeutic interventions in HCV patients. There is also an increased recognition of the importance of other viral hepatitis agents such as hepatitis delta and hepatitis E in the United States. This session will provide an overview of the laboratory’s role in the context of emerging technologies and current guidelines.
Patricia R. Slev, PhD, is the section chief of Immunology at ARUP and an associate professor of pathology at the University of Utah School of Medicine. She earned her PhD in immunology and laboratory medicine from the University of Florida, Gainesville and completed a fellowship in clinical chemistry at the University of Utah. Dr. Slev’s research interests are in immunogenetics and pathogen interactions, particularly HIV and viral hepatitis.
